Novel anesthetics in pediatric practice: is it time?
- 5 July 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Anaesthesiology
- Vol. 35 (4) , 425-435
Abstract
Purpose of review: Steadily mounting evidence of anesthesia-induced developmental neurotoxicity has been a challenge in pediatric anesthesiology. Considering that presently used anesthetics have, in different animal models, been shown to cause lasting behavioral impairments when administered at the peak of brain development, the nagging question, ‘Is it time for the development of a new anesthetic’ must be pondered. Recent findings: The emerging ‘soft analogs’ of intravenous anesthetics aim to overcome the shortcomings of currently available clinical drugs. Remimazolam, a novel ester-analog of midazolam, is a well tolerated intravenous drug with beneficial pharmacological properties. Two novel etomidate analogs currently in development are causing less adrenocortical suppression while maintaining equally favorable hemodynamic stability and rapid metabolism. Quaternary lidocaine derivatives are explored as more potent and longer lasting alternatives to currently available local anesthetics. Xenon, a noble gas with anesthetic properties, is being considered as an anesthetic-sparing adjuvant in pediatric population. Finally, alphaxalone is being reevaluated in a new drug formulation because of its favorable pharmacological properties. Summary: Although a number of exciting anesthetic drugs are under development, there is currently no clear evidence to suggest their lack of neurotoxic properties in young brain. Well designed preclinical studies are needed to evaluate their neurotoxic potential.Keywords
This publication has 89 references indexed in Scilit:
- The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: The importance of free oxygen radicals and mitochondrial integrityNeurobiology of Disease, 2012
- Duration and Local Toxicity of Sciatic Nerve Blockade With Coinjected Site 1 Sodium-Channel Blockers and Quaternary Lidocaine DerivativesRegional Anesthesia & Pain Medicine, 2012
- Cognitive and Behavioral Outcomes After Early Exposure to Anesthesia and SurgeryPediatrics, 2011
- Early Childhood Exposure to Anesthesia and Risk of Developmental and Behavioral Disorders in a Sibling Birth CohortAnesthesia & Analgesia, 2011
- Ketamine anesthesia during the first week of life can cause long-lasting cognitive deficits in rhesus monkeysNeurotoxicology and Teratology, 2011
- Early Exposure to Anesthesia and Learning Disabilities in a Population-based Birth CohortAnesthesiology, 2009
- The vanilloid receptor TRPV1 is activated and sensitized by local anesthetics in rodent sensory neuronsJournal of Clinical Investigation, 2008
- CNS 7056Anesthesiology, 2007
- Xenon Mitigates Isoflurane-induced Neuronal Apoptosis in the Developing Rodent BrainAnesthesiology, 2007
- Inhibition of Adrenal Steroidogenesis by the Anesthetic EtomidateNew England Journal of Medicine, 1984